Cervical swab test for detecting and monitoring endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a simple cervical swab (like a Pap smear) to see if it can help find or monitor endometrial cancer or precancerous changes. It aims to find a less invasive way to screen and follow up on this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need to have risk factors for endometrial cancer and be getting a hysteroscopy, OR you are being treated for endometrial lesions (like with hormones) and haven't had chemotherapy.
- You must be able to give written consent and be willing to come back for at least one check-up within a year.
- You must have an intact cervix (having had LEEP or conization is okay).
- You cannot have been treated for another gynecologic cancer, have had a hysterectomy, pelvic radiation, or have active bleeding or a weak immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to screen for cervical cancer by looking for certain DNA changes in a swab sample from the cervix. It may help find cancer or pre-cancer earlier, when it is easier to treat.
This study observes patients who need a scope exam or scraping of the uterus to look for conditions like polyps, fibroids, or cancer. It aims to gather information to improve care.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.